Morrison Foerster is an international law firm with lawyers practicing throughout the United States, Asia, and Europe. Click to discover more.

mofo_share_image.jpg

Morrison Foerster

common-default.jpeg

Terms / Notices

Cookies

Privacy Policy

Reporting Hotline

Attorney Advertising

Alumni

  Linkedin

MoFo LinkedIN

  Facebook

MoFo Facebook

YouTube

MoFo Youtube

Morrison Foerster - Footer

The 26th Hong Kong In-House Community Congress 2024: Sanctions and Export Controls

You have not solved the recaptcha challenge yet or session expired, try again.

Email Disclaimer

Disclaimer

Unsolicited e-mails and information sent to Morrison Foerster will not be considered confidential, may be disclosed to others pursuant to our <a href="https://www.mofo.com/about/privacy-policy.html">Privacy Policy</a>, may not receive a response, and do not create an attorney-client relationship with Morrison Foerster. If you are not already a client of Morrison Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.

Feedback

mofo-logo-2022.svg

People

Capabilities

Resources

About

Culture

Offices

Careers

Stay Connected

Morrison Foerster is proud to sponsor the 26th Hong Kong In-House Community Congress 2024, which brings together leading in-house lawyers, CEOs, company directors, and compliance professionals from both the private and public sectors in Hong Kong.

Morrison Foerster is proud to sponsor the 26th Hong Kong In-House Community Congress 2024, which brings together leading in-house lawyers, CEOs, company directors, and compliance professionals from both the private and public sectors in Hong Kong.Our Hong Kong dispute resolution partner B. Chen Zhu and Shanghai associate Derik Rao will be speaking on the topic of “Sanctions and Export Controls: Understanding the Latest Developments, U.S. Regulators’ Priorities, and Impacts on MNCs’ Operations in Greater China” during the congress. As sanctions and export controls stemming from conflicts in Europe and the Middle East expanded further in 2024, trade and geopolitical tensions between the United States and China continue to grow. This session will cover these developments and their impact on value chains and business activities in Greater China and APAC more broadly, including an overview of:<ul><li>Overview of key sanctions developments in 2024</li><li>Demystifying when “secondary sanctions” pose a real risk</li><li>Strategies deployed by corporates and banks to mitigate sanctions exposure</li></ul><a href="https://www.inhousecommunity.com/events/hong-kong-house-community-congress-2024/" target="_blank">Learn more about this event</a> and our <a href="/capabilities/national-security" target="_self">Sanctions + Export Controls practice</a>. <hr>

The 26th Hong Kong In-House Community Congress 2024: Sanctions and Export Controls

Sign Up

Chen is a partner whose practice focuses on government and internal investigations, cross-border enforcement matters and commercial litigation. He has extensive experience advising on U.S. economic sanctions, anti-money laundering, Foreign Corrupt Practices Act (FCPA), securities and accounting fraud, and related governance and corporate compliance issues. Chen also has extensive experience conducting compliance due diligence and designing compliance programs for clients in connection with private equity portfolio investments, M&A and IPO transactions. He also has experience in U.S.-based civil litigation involving Asia-based defendants. In addition, Chen frequently guides corporate and financial institutions clients through risk management issues associated with state secrecy, data privacy and cross-border data export control.His clients include major state-owned enterprises, multinational corporations and individuals from various industries including banking, pharmaceutical, technology, entertainment, insurance, consumer retail and hospitality, with a particular focus on China, Japan and Southeast Asia.Chen has been recognized as a Future Leader by Who’s Who Legal Investigations 2019 - 2022.Chen is a frequent presenter at legal conferences and client workshops relating to anti-corruption, economic sanctions and white-collar enforcement.Prior to joining Morrison Foerster, he worked in the Hong Kong and New York offices of a leading U.S. law firm. Chen is a native speaker of English and Mandarin. He is a Registered Foreign Lawyer with the Law Society of Hong Kong.

朱晨昊律师的执业重点为政府与内部调查、跨境执法事宜以及商业诉讼。他在针对美国经济制裁、反洗钱、美国《反海外腐败法》（FCPA）、证券和会计欺诈以及相关政府和公司合规问题提供法律意见方面拥有丰富的经验。朱律师在针对私募股权资产组合投资、并购和IPO交易为客户开展合规尽职调查以及设计合规计划方面拥有丰富的经验。他在处理涉及亚洲被告的美国民事诉讼事宜方面也具备经验。此外，朱律师亦经常协助公司和金融机构客户处理与国家机密、数据隐私和跨境数据出口管制有关的风险管理问题。朱律师的客户包括银行、医药、技术、娱乐、保险、消费品零售以及酒店业等多个行业的大型国有企业、跨国公司以及个人，其业务重点是中国、日本和东南亚地区。2019年 - 2020年《法律名人录》和2019年 - 2020年《全球调查评论》均将朱律师评为“公司调查领域的未来领袖律师”。朱律师是美富（国际）律师事务所的合伙人。在加入美富之前，朱律师在一家顶级美国律所的香港和纽约办事处任职。朱律师的母语是英文和中文。他是香港律师会的注册外国律师。

B. Chen Zhu

Partner

饶宇律师的执业范畴主要包括合规、监管、制裁、白领罪案事宜，以及《反海外腐败法》（FCPA）相关调查事宜。饶律师曾为金融、医疗保健、科技、电讯、加密货币等各行业的跨国公司提供法律意见，也曾代表美国、中国、日本及欧洲的企业处理各类FCPA及其他内部调查事宜，其中涉及商业欺诈、数据隐私、挪用公款和违反信托责任。饶律师还协助银行、投资基金以及其他金融机构管理与制裁有关的风险。此外，饶律师曾在各类证券集体诉讼、监管机构调查及平行诉讼中，为多家纽约证券交易所上市公司进行辩护。他还针对美国刑事和民事诉讼（包括证券集体诉讼、监管调查以及与电信欺诈、经济间谍和盗取知识产权有关的刑事诉讼）为中国大陆、香港和新加坡的个人客户进行辩护。在加入美富前，饶律师曾任职于加州某领先的国际律师事务所。饶律师毕业于华盛顿大学圣路易斯分校，以优等成绩获得法律博士学位。在就读法学院期间，他曾担任密苏里州联邦法官的外派实习生，期间曾草拟多份意见书。在就读法学院前，他曾于某国际知名的会计师事务所担任资深并购顾问。饶律师精通英语及普通话。<h4>具有代表性的项目</h4><ul><li>代表多家中国和香港特别行政区的大型银行处理美国制裁法下的银行合规和制裁风险相关事宜。</li><li>代表一家领先的美国制药公司处理与其在中国和其他亚洲市场开展运营有关的各种内部调查和相关FCPA风险评估事宜。</li><li>代表一家领先的美国咨询集团公司处理其中国子公司的相关内部调查事宜。</li><li>代表一家美国大型金融机构处理在美国纽约南区地方法院进行的与若干性骚扰指控有关的调查和平行民事诉讼事宜。</li><li>代表一家大型跨国半导体技术公司处理其在中国进行投资、研发和运营的相关内部调查事宜。</li></ul><ul><li>代表一家美国汽车技术公司处理在美国加州南区地方法院进行的针对一家中国对方当事人提起的商业秘密侵权诉讼事宜。</li><li>代表中国某领先的通讯科技公司处理FCPA调查事宜，其中涉及其亚洲、南美州及非洲业务。曾参与其与美国司法部之间的和解磋商。</li><li>代表加州某国际领先的通讯公司处理多项科技出口管制与数据隐私调查事宜，协助其回应美国司法部及大陪审团的多项传召出庭令。</li><li>代表欧洲某跨国医疗装置生产商处理与其在非洲和中东地区开展运营相关的FCPA内部调查事宜。</li><li>代表一家美国资产管理公司处理与其设在墨西哥的子公司有关的FCPA内部调查以及相关并购尽职调查事宜。</li><li>代表中国某领先的机构投资者处理美国多个州的商业欺诈调查事宜，以及特拉华州衡平法法院的案值数十亿美元的平行民事审讯事宜。</li><li>协助美国某领先的财富管理公司应对美国司法部就《商品交易法》所进行的调查事宜。</li><li>代表一家在纽约交易所上市的中国区块链公司处理商业欺诈调查及相关证券集体诉讼事宜，并为董事会与其他高级行政人员提供关于美国证券法例的合规事务培训。</li><li>代表一家中国投资公司及其美国和开曼群岛子公司处理在旧金山高等法院进行的股东争议诉讼事宜。</li><li>代表一家位于加州的软件公司处理对第三方传票做出答复事宜。该传票系关于备受瞩目的受托责任诉讼。</li><li>代表一家加州生物技术公司处理与各中国业务合伙人之间发生的多个合约争议事宜。</li><li>代表一家加拿大运输公司处理在美国伊利诺斯州中区地方法院进行的合同争议事宜。</li><li>代表某个人客户处理在第八巡回上诉法院和美国乔治亚州北区地方法院进行的美国联邦银行欺诈刑事诉讼事宜。</li><li>代表个人客户处理对第三方要求作证传票做出答复事宜。该传票系关于涉及多家大型国际银行的备受瞩目的反垄断集体诉讼。</li></ul>

Derik’s practice primarily focuses on compliance, regulatory, sanctions, export control, and white-collar matters, as well as investigations under the Foreign Corrupt Practices Act (FCPA) and other anti-bribery laws.He has experience advising multinational companies in finance, healthcare, technology, telecommunications, cryptocurrency, and various other industries. Derik represents corporate clients based in the United States, China, Japan, and Europe in various FCPA and other internal investigations, including in matters relating to commercial bribery, fraud, data privacy, embezzlement, and breach of fiduciary duties. He has extensive experience representing multinational pharmaceutical and medical device companies in conducting sensitive investigations and designing systematic remediation programs. Derik has assisted leading healthcare, technology, investment portfolio, and consulting companies based in the United States and Europe in handling some of the most sensitive and impactful investigations in the APAC region, including matters that involve regulatory investigations, compliance monitorships, self-disclosures, and negotiations before the U.S. Department of Justice (DOJ).Derik also assists banks, investment funds, and other financial institutions in managing sanctions-related risks. Additionally, Derik has advised NYSE-listed companies on their defense in securities class actions, regulatory investigations, and parallel lawsuits. Derik also defends individual clients based in Mainland China, Hong Kong, and Singapore in connection with U.S. criminal and civil lawsuits, including securities class actions, regulatory investigations, and criminal lawsuits involving wire fraud, insider trading, economic espionage, and theft of intellectual property.Prior to joining MoFo, Derik worked at a leading international law firm in Palo Alto, California, where he represented various leading technology companies in internal investigations and commercial litigations. He received his J.D. cum laude from Washington University in St. Louis. While in law school, Derik externed for a federal judge in Missouri and drafted multiple opinions. Before law school, Derik was a senior M&A consultant at a world-leading accounting firm.Derik is fluent in English and Mandarin.<h4>Representative Experience</h4><h5>Internal and Government Investigations</h5><ul><li>A world-leading pharmaceutical company based in the United States in various internal investigations and remediation projects concerning its operations in China, South Korea, and EMEA.</li><li>A Fortune 500 healthcare company based in the United States in various internal investigations concerning its operations in China that involve anti-bribery, embezzlement, data privacy, and accounting fraud issues.</li><li>A leading Chinese communication technology company in certain FCPA internal investigations concerning its operations in Asia, South America, and Africa; engaged in settlement negotiations with DOJ.</li><li>A world-leading professional service firm based in the United States in multiple internal anti-bribery investigations concerning its operations in China.</li><li>A leading Chinese institutional investor in certain business fraud investigations in various states in the United States and a parallel multibillion-dollar civil trial before the Delaware Court of Chancery.</li><li>A Europe-based healthcare company listed on the NASDAQ in a six-month compliance remediation project for its operations in China.</li><li>A world-leading communications company based in California in certain technology export control and data privacy investigations in response to various DOJ and grand jury subpoenas.</li><li>A leading U.S. agricultural company in certain internal investigations concerning its subsidiary in China and related commercial fraud issues.</li><li>A multinational European medical device manufacturer in certain FCPA internal investigations.</li><li>A NASDAQ-listed medical device manufacturer based in Europe in certain internal investigations and anti-bribery remediation matters concerning its operations in China.</li><li>A leading U.S. wealth management company in response to certain DOJ investigations under the Commodity Exchange Act.</li><li>A Chinese blockchain company listed on the New York Stock Exchange in certain commercial fraud investigations and a related securities class action; provided compliance training on U.S. securities laws to the client’s board of directors and senior executives.</li></ul><h5>Sanctions and Export Controls</h5><ul><li>A cutting-edge U.S. technology company in an internal investigation concerning alleged export violations relating to its operations in China.</li><li>A large Chinese bank’s subsidiary in Hong Kong in various commercial sanctions matters, including matters that involve U.S. sanctions regimes relating to Russia, Mainland China, Hong Kong SAR, Iran, and North Korea.</li><li>A large multinational telecommunication service provider headquartered in Asia in export control and commercial sanctions matters.</li><li>A Fortune 500 Chinese bank in various U.S. sanctions-related matters concerning its operations in Hong Kong.</li><li>A large Chinese bank’s subsidiary in Hong Kong in establishing a sanctions compliance program, including sanctions monitoring tools.</li><li>A leading Chinese insurance company’s overseas investment function in handling various matters under the U.S. sanctions regimes relating to Russia, Mainland China, and Hong Kong SAR.</li><li>A large Europe-based bank with extensive operations in China in assessing sanctions and export control risks and establishing a sanctions compliance program.</li><li>A leading Chinese sovereign wealth fund in certain matters concerning U.S.-initiated sanctions against Russia and China.</li></ul><h5>Litigation and Arbitration</h5><ul><li>A major U.S. online retail platform in a series of arbitrations concerning labor/employment and gig economy disputes before the American Arbitration Association (AAA).</li><li>A Chinese asset management firm and its U.S. subsidiaries in certain shareholder dispute lawsuits before the San Francisco Superior Court.</li><li>A major Chinese insurance group company and its U.S. subsidiaries in a US$4 billion contract dispute trial before the Delaware Court of Chancery, the appeal before the Delaware Supreme Court, and parallel anti-fraud investigation matters before various California state courts.</li><li>A Chinese block chain company listed on the New York Stock Exchange in a securities class action before the United States District Court for the District of New Jersey, and a parallel internal investigation.</li><li>A major Canadian transportation group company in a contract dispute before the United States District Court for the Central District of Illinois.</li></ul>

The 26th Hong Kong In-House Community Congress 2024: Sanctions and Export Controls

17 Oct 2024 10:20 AM - 11:30 AM HKT